Lifestyle, Fitness Boost Breast Cancer Chemotherapy Tolerance

A significant study, featured in the European Medical Journal (EMJ) on March 29, 2026, underscores the crucial role of lifestyle factors, particularly fitness levels and body composition, in shaping the outcomes of breast cancer chemotherapy. The article, based on findings from a large prospective cohort study published in the British Journal of Cancer, reveals that patients with higher fitness and healthier body composition demonstrate improved tolerance to chemotherapy. The research specifically highlights that higher relative dose intensity (RDI), a measure of how much chemotherapy a patient receives compared to the prescribed amount, was negatively associated with markers of adiposity, such as body mass index (BMI), waist circumference, waist-to-hip ratio, and fat mass percentage. Conversely, favorable body composition metrics, including a higher lean body mass percentage and lean-to-fat mass ratio, were positively linked to achieving higher RDI. This indicates that patients with a healthier body composition are more likely to receive optimal chemotherapy dosing. Furthermore, the study found that greater cardiorespiratory fitness and muscular strength showed positive dose-response relationships with chemotherapy tolerance. This implies that patients with higher aerobic capacity and muscle strength were better equipped to tolerate the demanding nature of chemotherapy. While the influence of these lifestyle factors on direct treatment response (pathologic complete response, pCR) was less consistent, a higher lean-to-fat mass ratio was still positively associated with pCR. In contrast, higher BMI and self-reported physical activity showed negative associations with this outcome, suggesting a complex interplay between various lifestyle elements and treatment efficacy. The European Medical Journal, an online, peer-reviewed, open-access publication established in 2012, plays a vital role in disseminating medical advancements. Its articles undergo a double-blind peer-review process, ensuring scientific rigor and credibility. The EMJ's commitment to advancing knowledge globally makes this study's findings accessible to a wide audience of healthcare professionals. These findings are corroborated by other robust research. A study led by Roswell Park Comprehensive Cancer Center in May 2023 demonstrated that high-risk breast cancer patients who adhered closely to cancer-prevention guidelines—including not smoking, eating a variety of fruits, vegetables, and whole grains, maintaining a healthy weight, being physically active, and limiting alcohol and red/processed meats—experienced a 37% reduced risk of disease recurrence and a 58% reduced risk of death. The two most impactful factors were strong adherence to smoking cessation and physical activity recommendations. Similarly, a Yale Cancer Center study published in September 2023 indicated that targeted diet and exercise interventions could improve outcomes for women undergoing breast cancer chemotherapy. While this intervention did not significantly increase RDI, researchers observed a surprising and positive association with pathologic complete response, with 53% of the intervention group achieving pCR compared to 28% in the control group. This suggests that diet and exercise might influence chemotherapy outcomes through mechanisms beyond just the completed dose. Additional evidence from the Anticancer Fund in November 2025 supports that specific lifestyle changes during chemotherapy can positively impact women with advanced breast cancer. A combined diet-and-exercise weight-loss program showed potential benefits, including preventing cancer progression for longer durations and improving emotional well-being, reducing anxiety and depression. The American Society of Clinical Oncology (ASCO) has also issued guidelines recommending exercise during active treatment, based on evidence that it maintains or improves cardiorespiratory fitness, strength, and reduces fatigue. For an Indian audience, these findings carry significant weight. Breast cancer has become the most common cancer among Indian women, with incidence rates more than doubling in the past three decades. Projections for 2050 indicate a substantial increase in both incidence and mortality. Lifestyle factors such as obesity, poor sleep, high-fat diets, red and processed meat consumption, and lack of physical activity are increasingly recognized as contributors to this surge in India, affecting younger women disproportionately. The economic burden of breast cancer in India is also alarming, projected to reach nearly $14 billion by 2030. The increasing prevalence of breast cancer, coupled with the rising impact of modifiable lifestyle factors, makes this research particularly relevant for India. Promoting healthy lifestyles—including regular physical activity, maintaining a healthy weight, and a balanced diet—can not only aid in cancer prevention but also significantly improve the tolerability and potentially the efficacy of vital treatments like chemotherapy, thereby improving the overall prognosis and quality of life for breast cancer patients in India.

Frequently Asked Questions

Read Full Story on Quick Digest